Congratulations to Dr. Dennis Ko, recipient of the 2024 CIHR-ICRH | L'ISCR des IRSC / CCS 2024 Distinguished Lecturer Award for advancing cardiovascular sciences in Canada and internationally.

Honored and grateful to receive the CIHR-ICRH | L'ISCR des IRSC Distinguished Lecturer Award! This achievement wouldn’t have been possible without the incredible support and mentorship I’ve received. Special thanks to Mak Lab, Brahmajee Nallamothu, Maneesh Sud, and Harindra Wijeysundera for nominating me

A prospective, multicenter, randomized controlled trial comparing VDD-ICD with VVI-ICD in detecting subclinical atrial fibrillation in patients with ICDs: the Dx-AF trial, by Mohammed Shurrab MD MSc PhD, Eugene Crystal MD FRCPC, and colleagues heartrhythmopen.com/article/S2666-…

Interesting study 💫 I’ve always found a VDD lead to be useful for patients without a clear indication for an atrial lead but at high risk for atrial arrhythmias #EPeeps Mohammed Shurrab MD MSc PhD Eugene Crystal MD FRCPC Heart Rhythm O2 Jeanne E Poole

A prospective, multicenter, randomized controlled trial comparing VDD-ICD with VVI-ICD in detecting subclinical atrial fibrillation in patients with ICDs: The Dx-AF trial, by Mohammed Shurrab MD MSc PhD, Eugene Crystal MD FRCPC, and colleagues heartrhythmopen.com/article/S2666-…

Huge congratulations Dennis Ko!! I am so lucky to have you as a mentor, a colleague and a friend!! ICES CCS

Comparative Effectiveness and Safety of Apixaban and Rivaroxaban in Older Patients with Atrial Fibrillation: A Population-Based Cohort Study Mohammed Shurrab MD MSc PhD heartrhythmjournal.com/article/S1547-…

Risk of stroke with reduced dose direct oral anticoagulants vs standard dose anticoagulation after cardioversion of atrial fibrillation, by Mohammed Shurrab MD MSc PhD et al. NOSM University | Université EMNO Queen's University PHRI.ca Population Health Research Institute 🇨🇦 McMaster University Dalhousie University Sunnybrook Health Sciences Centre IHPME Health Sciences North / Horizon Santé-Nord heartrhythmopen.com/article/S2666-…

Many patients ask about the safety of reduced-dose DOACs for fear of bleeding/bruising 🩸 ➡️Meta-analysis reveals higher numerical risk of thromboembolic events during cardioversion for #Afib compared to standard dose. 🔷Safety concerns persist (despite not reaching statistical

Here is an important paper from Mohammed Shurrab MD MSc PhD which will have a significant clinical impact Unruly Yak ⬛️🟨 Dennis Ko

Concurrent use of #amiodarone is associated with an increased risk of major bleeding in patients on #DOACs. Read more in a new study in #EHJPharmacotherapy 💊 👉 academic.oup.com/ehjcvp/advance… EHJ-CVP Editor-in-Chief 👨‍⚕️ European Society of Cardiology Journals 📚 European Society of Cardiology ❤️ #Cardiology #CardioMed #CardioEd

Mohammed Shurrab MD MSc PhD

🎓 Exciting Speaker Alert! Dr. Mohammed Shurrab at the International Arrhythmia School! 🩺💡 He’ll cover Indications for Holter Monitoring & Device Choices—critical for arrhythmia care. 🔴 FINAL week for discounted registration! 🖱️ Register: winterarrhythmia.com #Arrhythmia

#Women pay a toll in #Afib too: can we change that?!? Latest data from #EHRA2025 just published on #EHJOpen! #OpenUpYourScience! Lavinia Baciu Silvia Castelletti Milica Aleksic Gianluigi Savarese Women As One

Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation at High or Low Bleeding Risk: A Population-Based Cohort Study Mohammed Shurrab MD MSc PhD heartrhythmopen.com/article/S1547-…

📢New Meta-analysis: Rate vs Rhythm Control in AF and Risk of Syncope, Falls & Pacing HeartRhythm Heart Rhythm Society Mohammed Shurrab MD MSc PhD #EPeeps #CardioTwitter *⃣Background While early rhythm control m.b. beneficial (EAST-AFNET 4; CASTLE-AF, EARLY-AF), rhythm therapy—especially with AADs—may

Risk of syncope and permanent pacing with rate versus rhythm control of atrial fibrillation: A systematic review and meta-analysis Mohammed Shurrab MD MSc PhD heartrhythmjournal.com/article/S1547-…

🫀 Data shows women developing AF after cardiac surgery face double the in-hospital mortality risk vs. men. The study calls for urgent attention to pre-op optimization, individualized monitoring, and sex-based research. Read more: doi.org/10.1093/ehjope… #WomensHealth